Civic Intelligence

Bioadvance DBA the Biotechnology Greenhouse of Southeastern Pennsylvania

990 • Fiscal year 2022 • EIN 46-0481876

Jul 01, 2021 to Jun 30, 2022 • Filed on Mar 23, 2023

Organization ProfileWWW.BIOADVANCE.COM

View Organization Page

Refreshing map…

170 N Radnor-chester Road 350Radnor, PA 19087

(610) 230-0536

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

7th percentile

0.00x

Higher debt load relative to assets than 7% of similar nonprofits.

2022 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2022

Liabilities / Revenue

23rd percentile

0.12x

Higher debt load relative to revenue than 23% of similar nonprofits.

2022 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2022

Net Margin

57th percentile

9.7%

Higher net margin than 57% of similar nonprofits.

2022 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2022

Top Officer Pay

54th percentile

$376,162

Higher top officer pay than 54% of similar nonprofits.

Top officer pay equals 14.9% of source-year revenue.

2022 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2022

Asset Growth

24th percentile

-8.8%

Faster asset growth than 24% of similar nonprofits.

2022 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2021 to 2022

Revenue Growth

21st percentile

-14%

Faster revenue growth than 21% of similar nonprofits.

2022 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2021 to 2022

Balance Sheet
Liabilities / Assets7th percentile

Assets

Down

$73,104,917

Down $7,085,894 (-8.8%) from 2021

Net Assets

Down

$72,803,351

Down $6,962,800 (-8.7%) from 2021

Liabilities

Down

$301,566

Down $123,094 (-29%) from 2021

Revenue And Expenses
Liabilities / Revenue23rd percentileNet Margin57th percentile

Revenue

Down

$2,523,586

Down $408,166 (-14%) from 2021

Expenses

Down

$2,278,521

Down $133,935 (-5.6%) from 2021

Net Income

Down

$245,065

Down $274,231 (-53%) from 2021

Historical Trend

Balance Sheet Trend

Asset Growth24th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100M$50M$0Assets 2010: $27,741,940Liabilities 2010: $477,969Net Assets 2010: $27,263,9712010Assets 2011: $27,011,673Liabilities 2011: $364,805Net Assets 2011: $26,646,8682011Assets 2012: $25,630,285Liabilities 2012: $540,305Net Assets 2012: $25,089,9802012Assets 2013: $26,647,958Liabilities 2013: $322,982Net Assets 2013: $26,324,9762013Assets 2014: $31,553,912Liabilities 2014: $465,297Net Assets 2014: $31,088,6152014Assets 2015: $28,978,459Liabilities 2015: $276,446Net Assets 2015: $28,702,0132015Assets 2016: $61,373,001Liabilities 2016: $614,234Net Assets 2016: $60,758,7672016Assets 2017: $60,962,570Liabilities 2017: $608,169Net Assets 2017: $60,354,4012017Assets 2018: $60,326,743Liabilities 2018: $637,973Net Assets 2018: $59,688,7702018Assets 2019: $66,045,472Liabilities 2019: $611,198Net Assets 2019: $65,434,2742019Assets 2020: $78,551,910Liabilities 2020: $650,521Net Assets 2020: $77,901,3892020Assets 2021: $80,190,811Liabilities 2021: $424,660Net Assets 2021: $79,766,1512021Assets 2022: $73,104,917Liabilities 2022: $301,566Net Assets 2022: $72,803,3512022Assets 2023: $81,948,557Liabilities 2023: $4,605,680Net Assets 2023: $77,342,8772023

Highlighted filing

2022

Assets$73,104,917
Liabilities$301,566
Net Assets$72,803,351
Open 2022 Filing

Operations Trend

Revenue Growth21st percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$40M$30M$20M$10M$0-$10MExpenses 2010: $2,263,8742010Revenue 2011: $1,054,718Expenses 2011: $2,129,907Net Income 2011: -$1,075,1892011Expenses 2012: $2,039,6442012Expenses 2013: $2,040,1512013Revenue 2014: $5,921,552Expenses 2014: $1,989,408Net Income 2014: $3,932,1442014Revenue 2015: $1,845,392Expenses 2015: $1,954,957Net Income 2015: -$109,5652015Revenue 2016: $36,568,950Expenses 2016: $1,997,694Net Income 2016: $34,571,2562016Revenue 2017: $2,547,864Expenses 2017: $2,048,992Net Income 2017: $498,8722017Revenue 2018: $2,635,201Expenses 2018: $2,254,734Net Income 2018: $380,4672018Revenue 2019: $2,558,906Expenses 2019: $2,427,191Net Income 2019: $131,7152019Revenue 2020: $12,959,074Expenses 2020: $2,328,525Net Income 2020: $10,630,5492020Revenue 2021: $2,931,752Expenses 2021: $2,412,456Net Income 2021: $519,2962021Revenue 2022: $2,523,586Expenses 2022: $2,278,521Net Income 2022: $245,0652022Revenue 2023: $1,586,292Expenses 2023: $2,508,519Net Income 2023: -$922,2272023

Highlighted filing

2022

Revenue$2,523,586
Expenses$2,278,521
Net Income$245,065
Open 2022 Filing
Jump To
Filing Snapshot
Filing Period
Jul 1, 2021 to Jun 30, 2022
Signed
Mar 23, 2023
Return Version
2021v4.2
Gross Receipts
$8,280,599
Mission and Program Overview

Mission

The biotechnology greenhouse of southeastern pennsylvania was established with funds from the commonwealth of pennsylvania's share of the national tobacco settlement to accelerate growth of the life sciences industry by transforming the southeast pennsylvania region's strength in biomedical research and development into commercial opportunities. Approximately $25 million of the original government grant funding has been dedicated for pre-seed or "gap" funding for promising therapeutic, biomedical device and related technology companies, in a program called the greenhouse fund. The greenhouse fund is designed to move promising scientific projects out of the laboratory and into commercial opportunities. Additional funds were set aside for initiatives to increase the region's strengths in biomedical informatics and clinical trials.

Bioadvance was established in 2001 as one of three life sciences greenhouses funded with a share of pennsylvania's national tobacco settlement revenues, to promote human health by supporting biomedical innovation in the southeastern pa region. Bioadvance dedicated $25 million of the original grant funding for pre-seed and early-stage funding to help move technologies to the next stage of development and to support the initiatives intended to increase the region's strength in biomedical informatics and clinical trials. Since the original grant funding was expended, bioadvance continues to support emerging life sciences companies in southeastern pa and the surrounding mid-atlantic region that are focused on technologies to improve human health. As of june 30, 2022, a total of $58.5 million has been invested by bioadvance in 104 companies and academic technologies.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$36,517,099$29,824,613▼ $6,692,486
Investments Program Related$25,899,515$28,170,376▲ $2,270,861
Investments in Publicly Traded Securities$17,546,026$14,861,197▼ $2,684,829
Prepaid Expenses and Deferred Charges$152,749$155,063▲ $2,314
Cash and Non-Interest-Bearing Accounts$70,989$88,966▲ $17,977
Land, Buildings, and Equipment, Net$3,667$4,702▲ $1,035
Pledges and Grants Receivable$766$0▼ $766
Total Assets$80,190,811$73,104,917▼ $7,085,894
Liabilities
Accounts Payable and Accrued Expenses$424,660$301,566▼ $123,094
Total Liabilities$424,660$301,566▼ $123,094
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$79,766,151$72,803,351▼ $6,962,800
Total Net Assets Fund Balance$79,766,151$72,803,351▼ $6,962,800
Total Liabilities and Net Assets / Fund Balance$80,190,811$73,104,917▼ $7,085,894

Asset Categories

AssetBook ValueDepreciationBasis
Leasehold Improvements$0$165,927$165,927
Equipment$4,702$100,037$104,739
Investment Program Related Org$4,889,853--
Compensation and Service Providers
Top Officer Pay54th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Frederick JonesVP and SecretaryFT$274,737$101,425$376,162
Shahram HejaziCEO & Managing DirectorPT$272,405$94,786$367,191
Barbara S SchilbergDirector (CEO Thru 9/30/21)FT$238,152$69,786$307,938
Robert DriscollDirector of FinanceFT$186,777$62,330$249,107
Marnie MccoyProgram DirectorFT$129,382$15,380$144,762
Greg HarrimanVP and Asst SecretaryPT$60,629$640$61,269

Board Members and Trustees

NameTitle
J Larry Jameson Md PhdDirector
John GillDirector
Lauren LenfestDirector
Philip Gerbino PharmdDirector
STEPHEN D'ETTORREDirector
Steven Nichtberger MdDirector

Highest Paid Contractors

ContractorServicesLocationCompensation
Duane MorrisLegalPO BOX 787166, Philadelphia, PA 19178$127,384
Revenue and Support

Revenue Composition

Contributions and Grants
$1,000,000
Program Service Revenue
$798,023
Investment Income
$495,605
Other Revenue
$229,958
Change in Net Assets
$245,065

Audited Revenue Reconciliation

Revenue per Audited Statements
$1,597,600
Revenue Not Reported on Financial Statements
$925,986
Revenue Not Reported on Form 990
$0
Other Revenue Adjustments
$925,986
Total Revenue per Audited Statements
$1,597,600
Total Revenue per Form 990
$2,523,586
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$1,414,703
Other Expenses$863,818
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Current Officers, Directors, Trustees, and Key Employees$751,371$156,466-$907,837
Other Salaries and Wages$263,965$124,885-$388,850
Fees for Services Other$188,027$41,636-$229,663
Occupancy-$205,500-$205,500
Fees for Services Legal$151,440$1,740-$153,180
Insurance-$78,975-$78,975
Payroll Taxes$46,765$13,717-$60,482
Fees for Services Accounting-$46,750-$46,750
Other Employee Benefits$22,246$21,964-$44,210
Fees for Services Lobbying-$30,674-$30,674
Information Technology-$19,442-$19,442
Pension Plan Contributions$9,511$3,813-$13,324
Office Expenses-$6,411-$6,411
Conferences and Meetings-$5,245-$5,245
All Other Expenses$1,654$3,313-$4,967
Depreciation Depletion-$4,155-$4,155
Other Expenses$54,454$3,046-$3,046
Travel-$1,485-$1,485
Fees for Service Investment Mgmnt Fees-$242-$242
Total Functional Expenses$1,489,433$789,088$0$2,278,521

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$2,278,521
Total Expenses per Audited Statements$2,278,521
Total Expenses per Form 990$2,278,521
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“Before the form 990 is filed with the irs, the form is distributed to the organization's board of directors for their review and comments.”

Form 990, Part VI, Section B, Line 12C

“Periodically, the organization has its employees and board of directors sign a conflict of interest statement.”

Form 990, Part VI, Section B, Line 15

“Bioadvance recommended to the organization's compensation committee of the board of directors the salary increase for its ceo and officers for the year. After review and discussion, the compensation committee of the board of directors determined the appropriate salary increases.”

Form 990, Part VI, Section C, Line 19

“The organization's governing documents, conflict of interest policy and financial statements are available upon request.”

Filing and Contact Details

Filer

Filer Name
Bioadvance Dba the Biotechnology
EIN
46-0481876
Phone
6102300536
Address
170 N RADNOR-CHESTER ROAD 350, RADNOR, PA 19087
Doing Business As
The Biotechnology Greenhouse of Southeastern Pennsylvania

Signing Officer

Name
Shahram Hejazi
Title
CEO & Managing Director
Phone
6102300536
Signed
2023-03-23
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Shahram Hejazi
Formed
2002
Legal Domicile
Pa
Voting Board Members
7
Independent Board Members
6
Employees
6
Volunteers
6

Preparer

Firm
Eisner Advisory Group LLC
Address
130 NORTH 18TH STREET SUITE 3000, PHILADELPHIA, PA 19103-2757
Preparer
Helen M Martin
Phone
2158818800
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

“Consulting: program service expenses 188,027. Management and general expenses 41,636. Fundraising expenses 0. Total expenses 229,663.”

FORM 990, PART XI, LINE 9:

“Unrealized gain on portfolio investments -5,731,449.”

Financial Statement Notes

PART X, LINE 2:

“The internal revenue service has classified bioadvance as exempt from federal income taxes under section 501(c)(3) of the internal revenue code. U.s. Gaap requires management to evaluate tax positions taken and recognize a tax liability, if bioadvance has taken an uncertain tax position that more likely than not would not be sustained upon examination by a government authority. Management has analyzed the tax positions taken by bioadvance and has concluded that as of june 30, 2022 and 2021, there are no uncertain tax positions taken or expected to be taken that would require recognition of a liability or disclosure in the consolidated financial statements. Bioadvance recognizes interest and penalties associated with income taxes, if any, as part of interest and administrative expenses. There were no income tax related interest and penalties recorded for either of the years ended june 30, 2022 or 2021.”

PART XI, LINE 4B - OTHER ADJUSTMENTS:

“Realized gain on cash investments 127,963. Realized gain on portfolio investments 798,023.”

Raw XML AppendixShowing 400 of 627 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt0424660
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0301566
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0BIOADVANCE WAS ESTABLISHED IN 2001 AS ONE OF THREE LIFE SCIENCES GREENHOUSES FUNDED WITH A SHARE OF PENNSYLVANIA'S NATIONAL TOBACCO SETTLEMENT REVENUES, TO PROMOTE HUMAN HEALTH BY SUPPORTING BIOMEDICAL INNOVATION IN THE SOUTHEASTERN PA REGION. BIOADVANCE DEDICATED $25 MILLION OF THE ORIGINAL GRANT FUNDING FOR PRE-SEED AND EARLY-STAGE FUNDING TO HELP MOVE TECHNOLOGIES TO THE NEXT STAGE OF DEVELOPMENT AND TO SUPPORT THE INITIATIVES INTENDED TO INCREASE THE REGION'S STRENGTH IN BIOMEDICAL INFORMATICS AND CLINICAL TRIALS. SINCE THE ORIGINAL GRANT FUNDING WAS EXPENDED, BIOADVANCE CONTINUES TO SUPPORT EMERGING LIFE SCIENCES COMPANIES IN SOUTHEASTERN PA AND THE SURROUNDING MID-ATLANTIC REGION THAT ARE FOCUSED ON TECHNOLOGIES TO IMPROVE HUMAN HEALTH. AS OF JUNE 30, 2022, A TOTAL OF $58.5 MILLION HAS BEEN INVESTED BY BIOADVANCE IN 104 COMPANIES AND ACADEMIC TECHNOLOGIES.
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt03313
IRS990/AllOtherExpensesGrp/ProgramServicesAmt01654
IRS990/AllOtherExpensesGrp/TotalAmt04967
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0ROBERT DRISCOLL DIRECTOR OF FINANCE
IRS990/BooksInCareOfDetail/PhoneNum06102300536
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0170 N RADNOR-CHESTER ROAD SUITE 350
IRS990/BooksInCareOfDetail/USAddress/CityNm0RADNOR
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd019087
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt070989
IRS990/CashNonInterestBearingGrp/EOYAmt088966
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt01
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0156466
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0751371
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0907837
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt05245
IRS990/ConferencesMeetingsGrp/TotalAmt05245
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/ContractorCompensationGrp/CompensationAmt0127384
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt0PO BOX 787166
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0PHILADELPHIA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0PA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd019178
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0DUANE MORRIS
IRS990/ContractorCompensationGrp/ServicesDesc0LEGAL
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01000000
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt0495605
IRS990/CYOtherExpensesAmt0863818
IRS990/CYOtherRevenueAmt0229958
IRS990/CYProgramServiceRevenueAmt0798023
IRS990/CYRevenuesLessExpensesAmt0245065
IRS990/CYSalariesCompEmpBnftPaidAmt01414703
IRS990/CYTotalExpensesAmt02278521
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt02523586
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt04155
IRS990/DepreciationDepletionGrp/TotalAmt04155
IRS990/Desc0GREENHOUSE PROGRAM - THE CORNERSTONE OF BIOADVANCE INVESTMENT ACTIVITIES - WAS LAUNCHED TWO MONTHS AFTER RECEIVING THE DCED GRANT. THE PROGRAM FUNDS YOUNG COMPANIES FOR RESEARCH, DEVELOPMENT AND COMMERCIALIZATION ACTIVITIES THAT WILL PROVIDE ENOUGH PROGRESS TO ENABLE THEM TO ATTRACT VENTURE CAPITAL OR AN INDUSTRY PARTNER. INDIVIDUAL COMPANIES ARE ELIGIBLE TO RECEIVE UP TO $1,500,000 WHICH OFTEN IS DISBURSED AS MILESTONES ARE ACHIEVED, UNLESS THE CAP IS INCREASED BY THE BOARD. THE INVESTMENTS ARE IN THE FORM OF EQUITY OR A NOTE THAT CONVERTS INTO EQUITY UPON A SPECIFIED MINIMUM SIZE OF DOLLAR FUNDING.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DoingBusinessAsName/BusinessNameLine1Txt0THE BIOTECHNOLOGY GREENHOUSE OF SOUTHEASTERN PENNSYLVANIA
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt06
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt01489433
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt046750
IRS990/FeesForServicesAccountingGrp/TotalAmt046750
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt01740
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0151440
IRS990/FeesForServicesLegalGrp/TotalAmt0153180
IRS990/FeesForServicesLobbyingGrp/ManagementAndGeneralAmt030674
IRS990/FeesForServicesLobbyingGrp/TotalAmt030674
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt041636
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0188027
IRS990/FeesForServicesOtherGrp/TotalAmt0229663
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt0242
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt0242
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt132.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt20.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt30.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt40.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt840.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt924.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1140.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt025786
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt153458
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt859748
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt9640
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1043730
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1115380
IRS990/Form990PartVIISectionAGrp/PersonNm0BARBARA S SCHILBERG
IRS990/Form990PartVIISectionAGrp/PersonNm1SHAHRAM HEJAZI
IRS990/Form990PartVIISectionAGrp/PersonNm2STEPHEN D'ETTORRE
IRS990/Form990PartVIISectionAGrp/PersonNm3PHILIP GERBINO PHARMD
IRS990/Form990PartVIISectionAGrp/PersonNm4JOHN GILL
IRS990/Form990PartVIISectionAGrp/PersonNm5J LARRY JAMESON MD PHD
IRS990/Form990PartVIISectionAGrp/PersonNm6LAUREN LENFEST
IRS990/Form990PartVIISectionAGrp/PersonNm7STEVEN NICHTBERGER MD
IRS990/Form990PartVIISectionAGrp/PersonNm8FREDERICK JONES
IRS990/Form990PartVIISectionAGrp/PersonNm9GREG HARRIMAN
IRS990/Form990PartVIISectionAGrp/PersonNm10ROBERT DRISCOLL
IRS990/Form990PartVIISectionAGrp/PersonNm11MARNIE MCCOY
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0282152
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt1313733
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt8316414
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt960629
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10205377
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt11129382
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/TitleTxt0DIRECTOR (CEO THRU 9/30/21)
IRS990/Form990PartVIISectionAGrp/TitleTxt1CEO & MANAGING DIR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8VP AND SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt9VP AND ASST SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt10DIRECTOR OF FINANCE
IRS990/Form990PartVIISectionAGrp/TitleTxt11PROGRAM DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02002
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt0127963
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GovernmentGrantsAmt01000000
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt05884976
IRS990/GrossReceiptsAmt08280599
IRS990/GrossRentsGrp/RealAmt018000
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt06
IRS990/IndivRcvdGreaterThan100KCnt05
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt019442
IRS990/InformationTechnologyGrp/TotalAmt019442
IRS990/InsuranceGrp/ManagementAndGeneralAmt078975
IRS990/InsuranceGrp/TotalAmt078975
IRS990/InvestmentIncomeGrp/ExclusionAmt0234231
IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt0133411
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0367642
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsProgramRelatedGrp/BOYAmt025899515
IRS990/InvestmentsProgramRelatedGrp/EOYAmt028170376
IRS990/InvestmentsPubTradedSecGrp/BOYAmt017546026
IRS990/InvestmentsPubTradedSecGrp/EOYAmt014861197
IRS990/IRPDocumentCnt023
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0265964
IRS990/LandBldgEquipBasisNetGrp/BOYAmt03667
IRS990/LandBldgEquipBasisNetGrp/EOYAmt04702
IRS990/LandBldgEquipCostOrOtherBssAmt0270666
IRS990/LegalDomicileStateCd0PA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt05757013
IRS990/LessRentalExpensesGrp/RealAmt00
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0BIOADVANCE WAS ESTABLISHED IN 2001 AS ONE OF THREE LIFE SCIENCES GREENHOUSES FUNDED WITH A SHARE OF PENNSYLVANIA'S NATIONAL TOBACCO SETTLEMENT REVENUES, TO PROMOTE HUMAN HEALTH BY SUPPORTING BIOMEDICAL INNOVATION IN THE SOUTHEASTERN PA REGION. BIOADVANCE DEDICATED $25 MILLION OF THE ORIGINAL GRANT FUNDING FOR PRE-SEED AND EARLY-STAGE FUNDING TO HELP MOVE TECHNOLOGIES TO THE NEXT STAGE OF DEVELOPMENT AND TO SUPPORT THE INITIATIVES INTENDED TO INCREASE THE REGION'S STRENGTH IN BIOMEDICAL INFORMATICS AND CLINICAL TRIALS. SINCE THE ORIGINAL GRANT FUNDING WAS EXPENDED, BIOADVANCE CONTINUES TO SUPPORT EMERGING LIFE SCIENCES COMPANIES IN SOUTHEASTERN PA AND THE SURROUNDING MID-ATLANTIC REGION THAT ARE FOCUSED ON TECHNOLOGIES TO IMPROVE HUMAN HEALTH.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt079766151
IRS990/NetAssetsOrFundBalancesEOYAmt072803351
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0127963
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0127963
IRS990/NetRentalIncomeOrLossGrp/ExclusionAmt018000
IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt018000
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0-1476416
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt079766151
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt072803351
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt0205500
IRS990/OccupancyGrp/TotalAmt0205500
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt06411
IRS990/OfficeExpensesGrp/TotalAmt06411
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt0-5731449
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt021964
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt022246
IRS990/OtherEmployeeBenefitsGrp/TotalAmt044210
IRS990/OtherExpensesGrp/Desc0DATABASE
IRS990/OtherExpensesGrp/Desc1MEMBERSHIPS
IRS990/OtherExpensesGrp/Desc2SPONSORSHIPS
IRS990/OtherExpensesGrp/Desc3PAYROLL/403B PLAN FEES
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt012629
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt17000
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt23046
IRS990/OtherExpensesGrp/ProgramServicesAmt054454
IRS990/OtherExpensesGrp/TotalAmt054454
IRS990/OtherExpensesGrp/TotalAmt112629
IRS990/OtherExpensesGrp/TotalAmt27000
IRS990/OtherExpensesGrp/TotalAmt33046
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0124885
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0263965
IRS990/OtherSalariesAndWagesGrp/TotalAmt0388850
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt013717
IRS990/PayrollTaxesGrp/ProgramServicesAmt046765
IRS990/PayrollTaxesGrp/TotalAmt060482
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt03813
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt09511
IRS990/PensionPlanContributionsGrp/TotalAmt013324
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt0766
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0152749
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0155063
IRS990/PrincipalOfficerNm0SHAHRAM HEJAZI
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0525990
IRS990/ProgramServiceRevenueGrp/Desc0NET GAIN ON PROGRAM-RELATED INVES
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0798023
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0798023
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01000765
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt0863681
IRS990/PYOtherExpensesAmt0756762
IRS990/PYOtherRevenueAmt0293756
IRS990/PYProgramServiceRevenueAmt0773550
IRS990/PYRevenuesLessExpensesAmt0519296
IRS990/PYSalariesCompEmpBnftPaidAmt01655694
IRS990/PYTotalExpensesAmt02412456
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt02931752
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0245065
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd01
IRS990/RentalIncomeOrLossGrp/RealAmt018000
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd01
IRS990/RevenueAmt01143392
IRS990/RoyaltiesRevenueGrp/RelatedOrExemptFuncIncomeAmt0211958
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt0211958
IRS990/SavingsAndTempCashInvstGrp/BOYAmt036517099
IRS990/SavingsAndTempCashInvstGrp/EOYAmt029824613
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01000000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01000765
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt01241666
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt01000000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01483332
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt05725763
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0579600
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0879393
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt02237090
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt01608758
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt01119889
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt06424730
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt01774286
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.47120
IRS990ScheduleA/PublicSupportPY170Pct00.48990
IRS990ScheduleA/PublicSupportTotal170Amt05725763
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01000000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01000765
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt01241666
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt01000000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt01483332
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt05725763
IRS990ScheduleA/TotalSupportAmt012150493
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleC/DirectContactLegislatorsAmt030674
IRS990ScheduleC/DirectContactLegislatorsInd01
IRS990ScheduleC/GrantsOtherOrganizationsInd00
IRS990ScheduleC/MailingsMembersInd00
IRS990ScheduleC/MediaAdvertisementsInd00
IRS990ScheduleC/NotDescribedSection501c3Ind00
IRS990ScheduleC/OtherActivitiesInd00
IRS990ScheduleC/PaidStaffOrManagementInd00
IRS990ScheduleC/PublicationsOrBroadcastInd00
IRS990ScheduleC/RalliesDemonstrationsInd00
IRS990ScheduleC/SupplementalInformationDetail/ExplanationTxt0BIOADVANCE PAID GREENLEE PARTNERS LLC FOR ITS SHARE OF FEES TO MEET WITH STATE LEGISLATORS TO ADVOCATE ON BEHALF OF BIOADVANCE AND TWO OTHER LIFE SCIENCE GREENHOUSES.
IRS990ScheduleC/SupplementalInformationDetail/FormAndLineReferenceDesc0PART II-B, LINE 1:
IRS990ScheduleC/TotalLobbyingExpendituresAmt030674
IRS990ScheduleC/VolunteersInd00
IRS990ScheduleD/EquipmentGrp/BookValueAmt04702
IRS990ScheduleD/EquipmentGrp/DepreciationAmt0100037
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt0104739
IRS990ScheduleD/ExpensesNotReportedAmt00
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt00
IRS990ScheduleD/ExpensesSubtotalAmt02278521
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt023255523
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt125000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt24889853
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc0COMMON & PREFERRED INVESTMENTS
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc1INVESTMENT IN PLSG ACCELERATOR
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc2NOTES RECEIVABLE
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd0F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd1F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd2F
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt00
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt0165927
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt0165927
IRS990ScheduleD/OtherRevenuesNotIncludedAmt0925986
IRS990ScheduleD/RevenueNotReportedAmt00
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt0925986
IRS990ScheduleD/RevenueSubtotalAmt01597600
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0THE INTERNAL REVENUE SERVICE HAS CLASSIFIED BIOADVANCE AS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. U.S. GAAP REQUIRES MANAGEMENT TO EVALUATE TAX POSITIONS TAKEN AND RECOGNIZE A TAX LIABILITY, IF BIOADVANCE HAS TAKEN AN UNCERTAIN TAX POSITION THAT MORE LIKELY THAN NOT WOULD NOT BE SUSTAINED UPON EXAMINATION BY A GOVERNMENT AUTHORITY. MANAGEMENT HAS ANALYZED THE TAX POSITIONS TAKEN BY BIOADVANCE AND HAS CONCLUDED THAT AS OF JUNE 30, 2022 AND 2021, THERE ARE NO UNCERTAIN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD REQUIRE RECOGNITION OF A LIABILITY OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. BIOADVANCE RECOGNIZES INTEREST AND PENALTIES ASSOCIATED WITH INCOME TAXES, IF ANY, AS PART OF INTEREST AND ADMINISTRATIVE EXPENSES. THERE WERE NO INCOME TAX RELATED INTEREST AND PENALTIES RECORDED FOR EITHER OF THE YEARS ENDED JUNE 30, 2022 OR 2021.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt1REALIZED GAIN ON CASH INVESTMENTS 127,963. REALIZED GAIN ON PORTFOLIO INVESTMENTS 798,023.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0PART X, LINE 2:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc1PART XI, LINE 4B - OTHER ADJUSTMENTS:

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2022 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$73,104,917
Liabilities
$301,566
Net assets
$72,803,351
Revenue
$2,523,586
Expenses
$2,278,521
Net income
$245,065
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2023Summary only. Only limited summary data is available for this year.$81.9$4.61$77.3$1.59$2.51$0.92
2022Detailed filing. Detailed filing data is available for this year.$73.1$0.30$72.8$2.52$2.28$0.25
2021Summary only. Only limited summary data is available for this year.$80.2$0.42$79.8$2.93$2.41$0.52
2020Summary only. Only limited summary data is available for this year.$78.6$0.65$77.9$13.0$2.33$10.6
2019Summary only. Only limited summary data is available for this year.$66.0$0.61$65.4$2.56$2.43$0.13
2018Summary only. Only limited summary data is available for this year.$60.3$0.64$59.7$2.64$2.25$0.38
2017Summary only. Only limited summary data is available for this year.$61.0$0.61$60.4$2.55$2.05$0.50
2016Summary only. Only limited summary data is available for this year.$61.4$0.61$60.8$36.6$2.00$34.6
2015Summary only. Only limited summary data is available for this year.$29.0$0.28$28.7$1.85$1.95$0.11
2014Summary only. Only limited summary data is available for this year.$31.6$0.47$31.1$5.92$1.99$3.93
2013Summary only. Only limited summary data is available for this year.$26.6$0.32$26.3$2.04
2012Summary only. Only limited summary data is available for this year.$25.6$0.54$25.1$2.04
2011Summary only. Only limited summary data is available for this year.$27.0$0.36$26.6$1.05$2.13$1.08
2010Summary only. Only limited summary data is available for this year.$27.7$0.48$27.3$2.26
Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2022 filings • 501(c)3 • $50M-$100M nonprofits